Hepatorenal syndrome: pathophysiology and management.
Wadei
Hani M
HM
Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Jacksonville, FL 32216, USA.
Mai
Martin L
ML
Ahsan
Nasimul
N
Gonwa
Thomas A
TA
D006530:Hepatorenal Syndrome / Q000175:diagnosis / Q000209:etiology / Q000401:mortality / Q000503:physiopathology* / Q000628:therapy*; D006801:Humans; D015994:Incidence; D016031:Liver Transplantation; D019168:Portasystemic Shunt, Transjugular Intrahepatic; D011379:Prognosis; D017582:Renal Replacement Therapy; D012307:Risk Factors; D016896:Treatment Outcome; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use
D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents